February 09, 2012

STAAR SURGICAL TO PRESENT AT BMO CAPITAL MARKETS FOCUS ON HEATHCARE CONFERENCE IN NEW YORK

MONROVIA, Calif., July 31 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced today that Barry G. Caldwell, President and Chief Executive Officer will present at the 2008 BMO Capital Markets Focus on Healthcare Conference at the Millennium Broadway Hotel on Tuesday, August 5th at 10:45am Eastern Time.

Interested parties can access a live audio web cast of the presentation at http://www.staar.com. A replay of the presentation will be available at the same location.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at http://www.staar.com.

     CONTACT:  Investors                      Media
               EVC Group                      EVC Group
               Douglas Sherk, 415-896-6820    Steve DiMattia 646-201-5445
               Dahlia Bailey, 415-896-5862

SOURCE STAAR Surgical Company